We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.3B
AUM Growth
+$580M
Cap. Flow
+$169M
Cap. Flow %
0.79%
Top 10 Hldgs %
35.94%
Holding
882
New
52
Increased
484
Reduced
289
Closed
51

Top Buys

Rank Stock Value
1
NGD
New Gold Inc
NGD
+$52.1M
2
VEEV icon
Veeva Systems
VEEV
+$37.6M
3
UNH icon
UnitedHealth
UNH
+$36.1M
4
NOW icon
ServiceNow
NOW
+$35.9M
5
B
Barrick Mining
B
+$35.9M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$43.4M
2
ESV
Ensco Rowan plc
ESV
+$38.4M
3
DIS icon
Walt Disney
DIS
+$35.1M
4
MCK icon
McKesson
MCK
+$34.8M
5
HSY icon
Hershey
HSY
+$33.4M

Sector Composition

Rank Sector Weight
1 Materials 56.36%
2 Technology 9.22%
3 Energy 7.08%
4 Healthcare 5.95%
5 Financials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
301
Mondelez International
MDLZ
$83.4B
$6.27M 0.03%
113,275
-589,391
-84% -$32.2M
DIS icon
302
Walt Disney
DIS
$171B
$6.2M 0.03%
47,581
-253,693
-84% -$35.1M
SLRC icon
303
SLR Investment Corp
SLRC
$704M
$6.08M 0.03%
294,477
+17,042
+6% +$350K
USB icon
304
US Bancorp
USB
$97.9B
$6.06M 0.03%
109,437
+6,284
+6% +$340K
BRSP
305
BrightSpire Capital
BRSP
$651M
$6.04M 0.03%
417,787
+30,359
+8% +$442K
TMO icon
306
Thermo Fisher Scientific
TMO
$214B
$6M 0.03%
20,587
+646
+3% +$185K
V icon
307
Visa
V
$701B
$5.99M 0.03%
34,795
+1,102
+3% +$196K
DHR icon
308
Danaher
DHR
$138B
$5.98M 0.03%
46,727
+1,480
+3% +$185K
BKNG icon
309
Booking.com
BKNG
$156B
$5.97M 0.03%
76,075
+2,425
+3% +$188K
SYK icon
310
Stryker
SYK
$135B
$5.97M 0.03%
27,608
+871
+3% +$187K
O icon
311
Realty Income
O
$61.1B
$5.9M 0.03%
79,391
+6,174
+8% +$433K
UPS icon
312
United Parcel Service
UPS
$88.9B
$5.81M 0.03%
48,510
-602
-1% -$68.8K
PNC icon
313
PNC Financial Services
PNC
$99.1B
$5.8M 0.03%
41,391
+1,315
+3% +$178K
C icon
314
Citigroup
C
$213B
$5.77M 0.03%
83,524
+2,619
+3% +$178K
GDS icon
315
GDS Holdings
GDS
$5.93B
$5.76M 0.03%
+143,700
New +$5.79M
AXP icon
316
American Express
AXP
$224B
$5.71M 0.03%
48,284
+1,644
+4% +$202K
RY icon
317
Royal Bank of Canada
RY
$287B
$5.71M 0.03%
70,327
+2,550
+4% +$199K
VTRS icon
318
Viatris
VTRS
$20.8B
$5.64M 0.03%
285,373
-165,231
-37% -$3.24M
ABT icon
319
Abbott
ABT
$188B
$5.64M 0.03%
67,425
+2,134
+3% +$181K
UNP icon
320
Union Pacific
UNP
$174B
$5.61M 0.03%
34,647
+3,300
+11% +$555K
ADP icon
321
Automatic Data Processing
ADP
$109B
$5.61M 0.03%
34,748
+1,101
+3% +$182K
GRNB icon
322
VanEck Green Bond ETF
GRNB
$184M
$5.6M 0.03%
210,000
-40,000
-16% -$1.07M
GH icon
323
Guardant Health
GH
$19.1B
$5.58M 0.03%
+87,471
New +$7.71M
ADBE icon
324
Adobe
ADBE
$105B
$5.58M 0.03%
20,192
+648
+3% +$189K
PYPL icon
325
PayPal
PYPL
$50.3B
$5.58M 0.03%
53,850
+1,690
+3% +$186K

Similar funds

VanEck Associates's Q3 2019 Portfolio in Review

As of Q3 2019, VanEck Associates held 882 positions worth $21.3B, up 2.8% from $20.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

VanEck Associates's Q3 2019 filing shows 52 new, 484 increased, 289 reduced and 51 closed positions. Its largest new stake was Veeva Systems: 234,351 shares worth $35.8M. The largest sale was Allergan plc, an estimated $43.4M.

By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 55% a quarter earlier, followed by Technology and Energy.

  • VanEck Associates's largest Q3 2019 buy was Veeva Systems: 234,351 shares worth $35.8M.
  • VanEck Associates added most to New Gold Inc in Q3 2019, an estimated $52.1M increase.
  • VanEck Associates's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $43.4M.
  • VanEck Associates fully exited Ensco Rowan plc in Q3 2019, selling an estimated $38.4M.
  • VanEck Associates's ten largest holdings make up 36% of its $21.3B portfolio in Q3 2019.
  • VanEck Associates opened 52 new positions and closed 51 in Q3 2019.
  • VanEck Associates's portfolio value rose 2.8% quarter-over-quarter to $21.3B.

Based on VanEck Associates's 13F filing for Q3 2019, filed 8 Nov 2019.